Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Bullboard (TSX:LABS)

View:
Comment by QContinuum1on Jul 24, 2024 3:42pm

RE:RE:RE:RE:First

If Pidduck isn't facepalming every time Strachan opens his mouth he oughta be.  Not sure what value he has or is showing to the business except for perhaps being the big dumb shield if things ...more  
Comment by CADInvestor12on Jul 24, 2024 3:19pm

RE:RE:RE:First

I feel like MPL is going to follow the samw growth trajectory as Acasta Enterprises in Q2/ 2020 ... mind you, different circumstances but I feel like it'll happen any time now, just don't know ...more  
Comment by subaru1on Jul 24, 2024 1:57pm

RE:RE:First

Totally with your numbers for the 2qrt if we are still at $10M, then we are stock at $0,07 for a long time. Teh 30 to 35% growth has to stay for many qrt not only one, MPL has to reach $100M of ...more  
Comment by Solid1on Jul 24, 2024 1:53pm

RE:RE:FDA approval

A new treatment with a generic of Epidiolex is not excluded by a patent! And where do you see that we have one of these partners? 
Comment by QContinuum1on Jul 24, 2024 1:43pm

RE:FDA approval

Don't agree.  Even without Epidiolex, there is enough business in Germany, Brazil and Australia to drive the SP to multiples from here. Pharma is the unicorn moonshot but I agree that we ...more  
Post by Solid1on Jul 24, 2024 1:35pm

FDA approval

Everything stands or falls with FDA approval - that's the only thing that counts. But you don't even know the pharmaceutical partner or the exact status. The notification may come at any time ...more  
Comment by QContinuum1on Jul 24, 2024 1:21pm

RE:RE:First

Thoughtful post CAD....and I don't disgree with most of what you're saying.  My point on the undervalued comment from Pidduck was that it makes no sense for him to make that statement and ...more  
Comment by CADInvestor12on Jul 24, 2024 12:32pm

RE:First

@ Starkicker/ QC CEO wasn't complaining or whining about the stock being undervalued, he's saying the stock is undervalued because it is. Don’t forget that the majority of his options have ...more  
Comment by QContinuum1on Jul 24, 2024 11:37am

RE:RE:RE:RE:RE:RE:RE:First

Agreed fully.  The CEO calling out the weakness and then saying nothing more in that call or the subsequent Q call is not acceptable.  It comes across as whining and not having an action ...more  
Comment by okgonowon Jul 24, 2024 10:28am

RE:RE:RE:RE:RE:RE:RE:First

SHOW ME DA MOOONNNEEEEEEYYYYYYY!!
Comment by Starkickeron Jul 24, 2024 10:15am

RE:RE:RE:RE:RE:RE:First

I agree there is potential, whether realized or not. However, when the CEO complains the SP is undervalued but offers no guidance or reasons to help improve it, it tells me there is no catalyst at the ...more  
Post by pidukson Jul 23, 2024 9:22pm

Therapy for CEO's boredom

...sounds like most around here need at least a little bit. Two separate analyses of tens of thousands of public comments filed about the federal government’s plan to move marijuana to Schedule III ...more  
Comment by Lvlchangeon Jul 23, 2024 8:46pm

RE:RE:RE:RE:RE:First

I'll help. SHOW ME THE MONEY!
Comment by QContinuum1on Jul 23, 2024 4:05pm

RE:RE:RE:RE:RE:First

As critical as I am with the perceived lack of movement, I don't think myself that if it moves, it will be slow (both revenue and SP).  If anything, I do believe we could expect a step ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities